The data demonstrates promising efficacy and a favorable safety profile for IBI343 in patients with advanced gastric cancer whose tumors express CLDN18.2. Gastric cancer is one of the most common ...

Over the past 2 decades, detection of early-stage gastric cancer has increased by more than 50%. This finding may be attributed to improved endoscopic imaging and increased utilization of upper ...